Page 2 - David Fredrickson News Today

Our podcast on markets, the economy and business. This week, why America’s new drug pricing rules are a hard pill to swallow | Podcasts

Can a CEO be worth $9 billion? Without a clear succession plan, investors should prepare for further swings. Today AstraZeneca’s shares are worth nearly twice that amount, and the group has thrived thanks to blockbusters like breast cancer treatment Lynparza, and bold M&A, such as the $39 billion purchase of rare disease specialist Alexion in the middle of the pandemic.

Lung cancer is a major global health concern and ranks as the deadliest type of cancer, accounting for approximately one in five cancer-related deaths

/PRNewswire/ -- CancerX, the public-private partnership that launched in March of this year to harness the power of innovation to help achieve the goals of the...

It is already changing how pharma companies make drugs

It is already changing how pharma companies make drugs

It is already changing how pharma companies make drugs | Business

AstraZeneca joins as the sixth pharma company, and the first non-US company, to file suit against the Biden Administration over Medicare drug pricing.

Covid vaccine maker AstraZeneca has sued the US government over legislation designed to lower prescription drug prices.

Cheaper drugs will harm research into rare diseases, claims Pharma giant